Drug-Induced Pulmonary Arterial Hypertension: Mechanisms and Clinical Management

Pulmonary arterial hypertension is a rare disease, with drug-induced causes even more uncommon, accounting for only 10% of cases in large registry series. Predisposing factors for drug-induced PAH have not been completely defined. This review summarizes drugs with definite, possible, or likely assoc...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Cardiovascular drugs and therapy Ročník 33; číslo 6; s. 725 - 738
Hlavní autori: Correale, Michele, Tricarico, Lucia, Grazioli, Davide, Formica, Ennio Sascia, Petrucci, Rossella, Persichella, Paola, Di Biase, Matteo, Brunetti, Natale Daniele
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: New York Springer US 01.12.2019
Springer Nature B.V
Predmet:
ISSN:0920-3206, 1573-7241, 1573-7241
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Popis
Shrnutí:Pulmonary arterial hypertension is a rare disease, with drug-induced causes even more uncommon, accounting for only 10% of cases in large registry series. Predisposing factors for drug-induced PAH have not been completely defined. This review summarizes drugs with definite, possible, or likely association to pulmonary hypertension and possible mechanisms involved in the occurrence of pulmonary hypertension. Controversies on mechanisms and on their role in pathophysiology were also shown. The possible synergism between drug abuse and HIV was discussed and the possible interactions of antiretroviral therapy in HIV subjects were analyzed. Furthermore, we reported clinical findings and possible management, specific for each class of drugs, in case of drug-induced PAH. Finally, we summarized into a unified algorithm possible management of drug-induced PAH.
Bibliografia:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ISSN:0920-3206
1573-7241
1573-7241
DOI:10.1007/s10557-019-06920-x